Compound Detail
CHEMBL540264
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Cl.Cn1cc(NC(=O)c2cc(NC(=O)c3cc(NC(=O)c4cc(NC=O)cn4C)cn3C)cn2C)cc1C(=O)NCCC(=N)N
Basic Information
| ChEMBL ID | CHEMBL540264 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | UPXBFIKRZPIRLW-UHFFFAOYSA-N |
| Parent Compound | CHEMBL1190135 |
| Active Moiety | CHEMBL1190135 |
1
Targets
3
Activities
1
Assay Types
0
PK Parameters
3
Publications
0
Known Names
Molecular Properties
603.6
MW (Da)
1.42
ALogP
10
HBA
7
HBD
215.1
PSA (Ų)
0.07
QED
2
Ro5 Violations
12
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 3 meas. best 9.38
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| L1210 CHEMBL386 | IC50 | 9.38 | 8.2167 | 0.4 | 3 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| L1210 | IC50 | = | 0.42 | nM | 9.38 | Inhibition of growth in L1210 leukemia cells resistant to doxorubicin(DX). | 10893305 |
| L1210 | IC50 | = | 1.2 | nM | 8.92 | Inhibition of growth in L1210 leukemia cells resistant to Tallimustine. | 10893305 |
| L1210 | IC50 | = | 445.0 | nM | 6.35 | In vitro antitumor activity evaluated against L1210 murine leukemia cell line | 10893305 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 10893305 | 10.1021/jm9911229 | L1210 | 5 |
| - | 10.1016/S0960-894X(01)80515-1 | L1210 | 4 |
| - | 10.1016/S0960-894X(01)80515-1 | Mus musculus | 1 |
Data from ChEMBL 36 via Core Engine